Advisor Group Holdings, Inc. Armata Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.12 - $4.92 $17,160 - $27,060	5,500 New	5,500 $23,000
Q2 2022 Aug 10, 2022	SELL	$2.97 - $5.4 $2 - $5	-1 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$3.9 - $6.32 $1,747 - $2,831	-448 Reduced 99.78%	1 $0
Q3 2021 Nov 05, 2021	SELL	$3.55 - $4.14 $124 - $144	-35 Reduced 7.23%	449 $2,000
Q4 2020 Feb 10, 2021	BUY	$2.65 - $3.94 $484 - $721	183 Added 60.8%	484 $1,000
Q3 2020 Nov 12, 2020	BUY	$2.96 - $4.04 $393 - $537	133 Added 79.17%	301 $1,000
Q2 2020 Aug 14, 2020	BUY	$2.98 - $4.2 $345 - $487	116 Added 223.08%	168 $1,000
Q1 2020 May 18, 2020	BUY	$2.58 - $4.85 $134 - $252	52 New	52 $0

1.38M

400

17.3K

Ticker ARMP
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,144,700
Market Cap $70.5M
Description
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.